Telomere DNA Binding, Cleavage and Anticancer Activity of [Cu(phendione)(Hpyramol)Cl]

Author(s): Palanisamy Uma Maheswari*, Renuga Duraisamy, Murugesan Kanagavel, Kalimuthusamy Natarajaseenivasan, Kadhar Mohamed Meera Sheriffa Begum, Ruckmani Kandasamy.

Journal Name: Current Chemical Biology

Volume 13 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The ligand Hpyramol is a redox active, which on coordination with Cu(II) cleaves DNA without any added reductant. Another ligand phendione is known for its wide application towards anticancer activities. We combined the ligands with CuCl2 to have an intercalation moiety and a redox active ligand in participation towards telomere DNA cleavage and anticancer activity.

Objective: In this study, our aim is to interact it with Human telomere DNA and to see their effects on cancer cells.

Methods: The complex [Cu(L)(L’)Cl] has interacted with the human telomere DNA sequence (TTAGGG), HTelo20. The HTelo20 was stabilized under both parallel and antiparallel G-quadruplex conformations and the complex [Cu(L)(L’)Cl] has interacted followed by circular dichroism spectroscopy and gel electrophoresis.

Results: The parallel G-quadruplex and randomly coiled conformations of HTelo20 were easily cleaved than the anti-parallel G-quadruplex conformation. The nature of DNA cleavage was found to be oxidative rather hydrolytic. The formation of phenoxyl radical species under electrochemical and controlled potential electrolysis conditions by the complex [Cu(L)(L’)Cl] proves the possibility of oxidative nature of DNA cleavage. The comet assay also proves the DNA cleavage induced by the complex [Cu(L)(L’)Cl] inside the nucleus of HeLa cancer cells.

Conclusion: The complex [Cu(L)(L’)Cl] was tested for anticancer activity, induced by ROS and DNA cleavage. The IC50 values resulted in nanomolar concentrations with selected cancer cell lines. Relatively the Cu complex shows less toxicity with the normal cell line L132.

Keywords: ROS, telomere, DNA cleavage, anti-cancer, hpyramol, phendione.

[1]
Sun D, Liu Y, Yu Q, Liu D, Zhou Y, Liu J. Selective nuclei accumulation of ruthenium(II) complex enantiomers that target G-quadruplex DNA. J Inorg Biochem 2015; 150: 90-9.
[2]
Sun J, An Y, Zhang L, et al. Studies on synthesis, characterization, and G-quadruplex binding of Ru(II) complexes containing two dppz ligands. J Inorg Biochem 2011; 105: 149-54.
[3]
Colangelo D, Ghiglia A, Viano I, et al. Might telomerase enzyme be a possible target for trans- Pt(II) complexes. J Inorg Biochem 2004; 98: 61-7.
[4]
aLi YL, Qin QP, Liu YC, Chen ZF, Liang H. A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization. J Inorg Biochem 2014; 137: 12-21.; bShi S, Huang HL, Gao X, et al. A comparative study of the interaction of two structurally analogous ruthenium complexes with human telomeric G-quadruplex DNA. J Inorg Biochem b 2013; 121: 19-27.
[5]
Le T, Han S, Chae J, Park HJ. G-quadruplex binding ligands: from naturally occurring to rationally designed molecules. Curr Pharm Des 2012; 18: 1948-72.
[6]
aXiong YX, Huang ZS, Tan JH. Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives. Eur J Med Chem 2015; 97: 538-51.; bKaushik M, Kaushik S, Bansal A, Saxena S, Kukreti S. Structural diversity and specific recognition of four stranded G- quadruplex DNA. Curr Mol Med 2011; 11: 744-69.; cHurley LH, Wheelhouse RT, Sun D, et al. G-quadruplexes as targets for drug design. Pharmacol Ther 2000; 85: 141-58.; dNeidle S, Read MA. G-quadruplexes as therapeutic targets. Biopolymers 2000; 56: 195-208.
[7]
a) Maheswari PU, Rajendran V, Palaniandavar M, Parthasarathi R, Subramanian V. Synthesis, characterization and DNA-binding properties of rac-[Ru(5,6-dmp)2(dppz)]2+-enantiopreferential DNA binding and co-ligand promoted exciton coupling. J Inorg Biochem 2006; 100: 3-17.; b) Maheswari PU, Barends S, et al. Unique ligand-based oxidative DNA cleavage by Zinc(II) complexes of Hpyramol and Hpyrimol. Chem Eur J 2007; 13: 5213-22.
[8]
aRoy S, Hagen KD, Maheswari PU, et al. Phenanthroline derivatives with improved selectivity as DNA- targeting anticancer or antimicrobial drugs. ChemMedChem 2008; 3: 1427-34.; bMaheswari PU, Roy S, Dulk HD, et al. The square-planar cytotoxic [Cu(pyrimol)Cl] complex acts as an efficient DNA cleaver without reductant. J Am Chem Soc 2006; 128: 710-1.
[9]
aWong YL, Dennis KP, Lee HK. New chloro, μ-Oxo, and alkyl derivatives of dioxomolybdenum(VI) and -tungsten(VI) complexes chelated with N2O tridentate ligands: Synthesis and catalytic activities toward olefin epoxidation. Inorg Chem 2002; 41: 5276-85.; bHoog PD, Pachon LD, Gamez P, Lutz M, Spek AL, Reedijk J. Solution-stable trinuclear zinc(II) cluster from 4-methyl-2-N-(2-pyridylmethylene)aminophenol (Hpyrimol). J Dalton Trans 2004; 17: 2614-5.
[10]
Özalp-Yaman S, Hoog PD, Maheswari PU, et al. Spectroelectrochemical studies of nuclease-active zinc(II) coordination compounds from the ligands Hpyramol and Hpyrimol. Electrochim Acta 2010; 55: 8655-63.
[11]
Husáriková L, Pepicka Z, Moncol J, Valigura D, Valko M, Mazur M. Unusual EPR spectra with inverse Axial g values of chloro salicylate –Cu(II)– 2,6-Pyridinedimethanol complex in frozen water–methanol solution. Appl Magn Reson 2013; 44: 571-82.
[12]
Maheswari PU, Harti F, Quesada M, et al. Spectro-electrochemical and DFT studies of a planar Cu(II)– phenolate complex active in the aerobic oxidation of primary alcohols. Inorg Chim Acta 2011; 374: 406-14.
[13]
Halfen JA, Victor G, Tolman WB. Modeling of the chemistry of the active site of galactose Oxidase. Angew Chem 1996; 35: 1687-90.
[14]
Benisvy L, Bill E, Blake AJ, et al. Phenoxyl radicals: H-bonded and coordinated to Cu(II) and Zn(II). Dalton Trans 2006; 1: 258-67.
[15]
Kieltyka R, Englebienne P, Fakhoury J, Autexier C, Moitessier N, Sleiman HF. A platinum supramolecular square as an effective G-quadruplex binder and telomerase inhibitor. J Am Chem Soc 2008; 130: 10040-1.
[16]
Olive PL, Banath JP. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 2006; 1: 23-9.
[17]
Karna P, Zughaier S, Pannu V, Simmons R, Narayan S, Aneja R. Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent. J Biol Chem 2010; 285: 18737-48.
[18]
Kim M, Kooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998; 91: 4106-17.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 2
Year: 2019
Page: [171 - 182]
Pages: 12
DOI: 10.2174/2212796813666190214112129
Price: $58

Article Metrics

PDF: 41
HTML: 3
PRC: 1